SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-042893
Filing Date
2021-08-10
Accepted
2021-08-10 08:01:47
Documents
83
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q fusn-10q_20210630.htm   iXBRL 10-Q 3783927
2 EX-31.1 fusn-ex311_9.htm EX-31.1 20439
3 EX-31.2 fusn-ex312_10.htm EX-31.2 20492
4 EX-32.1 fusn-ex321_7.htm EX-32.1 9389
5 EX-32.2 fusn-ex322_6.htm EX-32.2 9386
  Complete submission text file 0001564590-21-042893.txt   12648583

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA fusn-20210630.xsd EX-101.SCH 72730
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE fusn-20210630_cal.xml EX-101.CAL 71097
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE fusn-20210630_def.xml EX-101.DEF 206072
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE fusn-20210630_lab.xml EX-101.LAB 545956
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fusn-20210630_pre.xml EX-101.PRE 413523
11 EXTRACTED XBRL INSTANCE DOCUMENT fusn-10q_20210630_htm.xml XML 2531735
Mailing Address 270 LONGWOOD ROAD SOUTH HAMILTON A6 L8P 0A6
Business Address 270 LONGWOOD ROAD SOUTH HAMILTON A6 L8P 0A6 289-799-0891
Fusion Pharmaceuticals Inc. (Filer) CIK: 0001805890 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39344 | Film No.: 211158468
SIC: 2836 Biological Products, (No Diagnostic Substances)